C12N 2760/18522
New viral proteins or individual genes, new structural or functional aspects of
Official title: New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
C12N2760/18522 (New viral proteins or individual genes, new structural or functional aspects of) appears on 364 US grants and 478 published applications in this corpus.
Search patents in C12N- Granted patents
- 364
- Published applications
- 478
- Assignees
- 240
- Inventors
- 899
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 2 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 3 | 0 |
| 1998 | 10 | 0 |
| 1999 | 11 | 0 |
| 2000 | 25 | 0 |
| 2001 | 14 | 1 |
| 2002 | 12 | 7 |
| 2003 | 11 | 12 |
| 2004 | 13 | 17 |
| 2005 | 4 | 21 |
| 2006 | 3 | 12 |
| 2007 | 6 | 12 |
| 2008 | 7 | 14 |
| 2009 | 12 | 15 |
| 2010 | 13 | 25 |
| 2011 | 3 | 16 |
| 2012 | 4 | 14 |
| 2013 | 8 | 9 |
| 2014 | 11 | 22 |
| 2015 | 10 | 22 |
| 2016 | 10 | 16 |
| 2017 | 16 | 14 |
| 2018 | 14 | 16 |
| 2019 | 13 | 21 |
| 2020 | 13 | 21 |
| 2021 | 14 | 24 |
| 2022 | 22 | 30 |
| 2023 | 28 | 36 |
| 2024 | 15 | 37 |
| 2025 | 24 | 21 |
| 2026 | 8 | 23 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Cell culture process for producing RSV F protein15 Sep 2026US 12,734,231 B2Pfizer Inc.
- Conformationally stabilized RSV pre-fusion F proteins11 Aug 2026US 12,703,721 B2
- Virus-like particles containing RSV antigen protein and vaccines using the same12 May 2026US 12,622,958 B2University-Industry Cooperation Group of Kyung Hee University
- Modified virus-like particles of CMV21 Apr 2026US 12,605,454 B2Saiba GmbH
- Transient expression of biologic materials17 Mar 2026US 12,576,041 B1
- Immunogenic compositions against influenza and rsv17 Sep 2026US 2026/0273040 A1Pfizer Inc.
- Rsv vaccine composition, method and use thereof10 Sep 2026US 2026/0263581 A1Sichuan Clover Biopharmaceuticals, Inc.
- Modified virus-like particles of cmv10 Sep 2026US 2026/0263612 A1Saiba GmbH
- Antigenic Multimeric Respiratory Syncytial Virus Polypeptides10 Sep 2026US 2026/0265309 A1Sanofi
- Vaccine against respiratory syncytial virus infection13 Aug 2026US 2026/0232787 A1Westvac Biopharma Co., Ltd.
Most cited
By later US patents
- Cationic lipids and the use thereof249US 5,830,430 AImaRx Pharmaceutical Corp. · 1998
- Cationic lipids and the use thereof138US 6,056,938 AImarx Pharaceutical Corp. · 2000
- Prevention and treatment of respiratory tract disease115US 5,716,821 AThe UAB Research Foundation · 1998
- Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof110US 5,811,524 AIDEC Pharmaceuticals Corporation · 1998
- Stranded RNA virus particles108US 5,789,229 AThe UAB Research Foundation · 1998